Abstract
Presentation slides on Incremental Cost-Effectiveness of the 9-valent vs. the 4-valent HPV vaccine in the U.S. for the October 2014 ACIP meeting.
Background paper
Americas
United States of America
Human papillomavirus (HPV)
